It's Terminal || Death, Grief & Other Sh*t We Don't Discuss | Q102
Kyle McMahon's Death, Grief & Other Sh*t We Don't Discuss, Episode 2: It's Terminal
Stay updated with breaking news from Gregory Masters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kyle McMahon's Death, Grief & Other Sh*t We Don't Discuss, Episode 2: It's Terminal
Kyle McMahon's Death, Grief & Other Sh*t We Don't Discuss, Episode 2: It's Terminal
Kyle McMahon's Death, Grief & Other Sh*t We Don't Discuss, Episode 2: It's Terminal
This article is a collaboration between MedPage Today and: A year ago, ASCO released a clinical practice guideline on systemic therapy for patients with stage IV non-small cell lung cancer (NSCLC) without driver alterations. Part two has now been released, and it focuses on patients with stage IV NSCLC with driver alterations. The guideline "is a result of potentially practice-changing evidence published since the last update [in 2017]," noted Gregory Masters, MD, of the ChristianaCare Helen F. Graham Cancer Center and Research Institute in Newark, Delaware, and colleagues. The updated guide...